Drug Profile
BHT 3034
Alternative Names: BHT-3034Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Bayhill Therapeutics
- Class DNA vaccines
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Autoimmune disorders